INTERLEUKIN 4 HAS STATE-DEPENDENT THERAPEUTIC EFFICACY IN ACUTE MYELOID LEUKEMIA

被引：0
|
作者：
Pena-Martinez, Pablo [1 ]
Eriksson, Mia [2 ]
Ramakrishnan, Ramprasad [2 ]
Chapellier, Marion [2 ]
Hogberg, Carl [3 ]
Richter, Johan [2 ]
Fioretos, Thoas [2 ]
Jaras, Marcus [2 ]
机构：
[1] Lund Univ, Dept Clin Genet, Lund, Sweden
[2] Lund Univ, Lund, Sweden
[3] Lund Univ, Lund, Switzerland
来源：
EXPERIMENTAL HEMATOLOGY | 2016年 / 44卷 / 09期
关键词：
D O I：
10.1016/j.exphem.2016.06.204
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
3125
引用
收藏
页码：S96 / S96
页数：1
相关论文
共 50 条
  • [1] Csnk1a1 inhibition has p53-dependent therapeutic efficacy in acute myeloid leukemia
    Jaeras, Marcus
    Miller, Peter G.
    Chu, Lisa P.
    Puram, Rishi V.
    Fink, Emma C.
    Schneider, Rebekka K.
    Al-Shahrour, Fatima
    Pena, Pablo
    Breyfogle, L. Jordan
    Hartwell, Kimberly A.
    McConkey, Marie E.
    Cowley, Glenn S.
    Root, David E.
    Kharas, Michael G.
    Mullally, Ann
    Ebert, Benjamin L.
    JOURNAL OF EXPERIMENTAL MEDICINE, 2014, 211 (04): : 605 - 612
  • [2] THERAPEUTIC EFFICACY OF INHIBITOR OF MITOCHONDRIAL TRANSCRIPTION IN ACUTE MYELOID LEUKEMIA
    Arabanian, Laleh
    Gustafsson, Claes
    Palmqvist, Lars
    EXPERIMENTAL HEMATOLOGY, 2019, 76 : S56 - S56
  • [3] Interleukin-4 treatment reduces leukemia burden in acute myeloid leukemia
    Qian, Fenghua
    Arner, Brooke E.
    Kelly, Kathleen M.
    Annageldiyev, Charyguly
    Sharma, Arati
    Claxton, David F.
    Paulson, Robert F.
    Prabhu, K. Sandeep
    FASEB JOURNAL, 2022, 36 (05):
  • [4] Interleukin 4 induces apoptosis of acute myeloid leukemia cells in a Stat6-dependent manner
    P Peña-Martínez
    M Eriksson
    R Ramakrishnan
    M Chapellier
    C Högberg
    C Orsmark-Pietras
    J Richter
    A Andersson
    T Fioretos
    M Järås
    Leukemia, 2018, 32 : 588 - 596
  • [5] Interleukin 4 induces apoptosis of acute myeloid leukemia cells in a Stat6-dependent manner
    Pena-Martinez, P.
    Eriksson, M.
    Ramakrishnan, R.
    Chapellier, M.
    Hogberg, C.
    Orsmark-Pietras, C.
    Richter, J.
    Andersson, A.
    Fioretos, T.
    Jaras, M.
    LEUKEMIA, 2018, 32 (03) : 588 - 596
  • [6] Therapeutic efficacy of aryl hydrocarbon receptor agonist in acute myeloid leukemia
    Han, Hee Joo
    Shin, Dong-Yeop
    Yoon, Sung-Soo
    CANCER RESEARCH, 2019, 79 (13)
  • [7] CXCR4 as a therapeutic target in acute myeloid leukemia
    Korbecki, Jan
    Bosiacki, Mateusz
    Kupnicka, Patrycja
    Barczak, Katarzyna
    Chlubek, Dariusz
    Baranowska-Bosiacka, Irena
    LEUKEMIA, 2024, 38 (11) : 2303 - 2317
  • [8] Interleukin-4 Is a Negative Regulator of Acute Myeloid Leukemia Cells
    Martinez, Pablo Enrique Pena
    Chapellier, Marion
    Eriksson, Mia
    Ramakrishnan, Ramprasad
    Hogberg, Carl
    Jaras, Marcus
    BLOOD, 2014, 124 (21)
  • [9] Therapeutic Advances in Acute Myeloid Leukemia
    Burnett, Alan
    Wetzler, Meir
    Loewenberg, Bob
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (05) : 487 - 494
  • [10] Acute myeloid leukemia: therapeutic indications
    Burnett, AK
    Kell, J
    Rowntree, C
    CURRENT OPINION IN HEMATOLOGY, 2000, 7 (06) : 333 - 338
12345